First Eagle Investment Management’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.1M Sell
3,282,326
-388,961
-11% -$2.69M 0.04% 97
2026
Q2
$22.9M Buy
3,671,287
+1,146,951
+45% +$4.95M 0.04% 120
2026
Q1
$7.14M Buy
2,524,336
+725,000
+40% +$2.46M 0.01% 234
2025
Q4
$5.85M Buy
1,799,336
+1,348,405
+299% +$4.54M 0.01% 240
2025
Q3
$1.29M Buy
+450,931
New +$1.15M ﹤0.01% 325

Other funds holding MRVI

First Eagle Investment Management's MRVI Position: Q3 2026 in Review

First Eagle Investment Management reduced its Maravai LifeSciences (MRVI) stake by 11% in Q3 2026, selling an estimated $2.69M and leaving 3,282,326 shares worth $25.1M. The position accounts for 0.04% of the portfolio, ranked #97.

First Eagle Investment Management first reported a position in MRVI in Q3 2025 and has held it in 5 quarters since. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • First Eagle Investment Management held 3,282,326 shares of Maravai LifeSciences worth $25.1M as of Q3 2026.
  • First Eagle Investment Management sold 388,961 Maravai LifeSciences shares in Q3 2026, an estimated $2.69M.
  • Maravai LifeSciences made up 0.04% of First Eagle Investment Management's portfolio in Q3 2026, its #97 holding.
  • First Eagle Investment Management first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 5 quarters since.
  • 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on First Eagle Investment Management's 13F filing for Q3 2026, filed 10 Nov 2026.